About University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology
Clinical Trials at University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology
During the past decade, University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology"
#1 collaborator was "CZECRIN - Czech Clinical Research Infrastructure Network" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology
According to Clinical.Site data, the most researched conditions in "University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology" are
"Multiple Myeloma" (3 trials), "Heart Failure" (2 trials), "Newly Diagnosed" (2 trials), "Relapse Multiple Myeloma" (2 trials) and "Acute Lymphoblastic Leukemia, Adult" (1 trials). Many other conditions were trialed in "University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology" in a lesser frequency.
Clinical Trials Intervention Types at University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology
Most popular intervention types in "University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (3 trials), "Empagliflozin" (2 trials), "Blinatumomab" (1 trials), "Daratumumab" (1 trials) and "Gemcitabine + Rituximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology
The vast majority of trials in "University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology" are
9 trials for "All" genders.
Clinical Trials Status at University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology
Currently, there are NaN active trials in "University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".